Study on Dedifferentiation Mechanism of Anaplastic Thyroid Carcinoma Based on Single Cell Sequencing Technology
- Conditions
- Anaplastic thyroid carcinoma
- Registration Number
- ITMCTR2024000083
- Lead Sponsor
- Wangjing Hospital of China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Sex is not limited. The age is 18-95.
(2) Meet the diagnostic criteria of western medicine for anaplastic thyroid cancer or differentiated thyroid cancer. TCM symptoms meet the diagnostic criteria of TCM syndromes.
(3) The clinical data of each case are complete and true.
(4) Not treated with any medication for the disease.
(5) signed the informed consent form
(1) Patients with thyroid diseases other than thyroid cancer, including benign thyroid nodules, hyperthyroidism, thyroid
thyroid adenoma; thyroid inflammatory disease patients, including Hashimoto's thyroiditis, subacute thyroiditis,
Thyroid related eye diseases, etc.
(2) Allergy or known allergy to certain drugs.
(3) Patients with severe cardiovascular, cerebrovascular, liver, kidney and hematopoietic diseases, mania and schizophrenia requiring drug therapy.
(4) Patients with other tumors.
(5) Preparing for pregnancy, pregnant and lactating patients.
(6) Participants in other clinical trials within the last three months.
(7) History of neck radiation exposure.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method